AI Engines For more Details: Perplexity Kagi Labs You
Heart Health: Fatty fish such as salmon, mackerel, trout, and sardines are rich sources of omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omega-3 fatty acids have been associated with a reduced risk of cardiovascular disease by lowering triglyceride levels, reducing inflammation, improving blood vessel function, and lowering blood pressure. Regular consumption of fatty fish or omega-3 supplements may help reduce the risk of heart attacks, strokes, and other cardiovascular events.
Brain Health: Omega-3 fatty acids are essential for brain development and function. Adequate intake of omega-3s during pregnancy and early childhood may support cognitive development and reduce the risk of neurodevelopmental disorders such as ADHD and autism spectrum disorder. In adults, omega-3 fatty acids have been linked to better cognitive function, memory, and a reduced risk of age-related cognitive decline and dementia.
Eye Health: Omega-3 fatty acids, particularly DHA, are important for maintaining eye health and vision. Adequate intake of omega-3s may help prevent age-related macular degeneration (AMD), a leading cause of vision loss in older adults.
Inflammatory Conditions: Omega-3 fatty acids have anti-inflammatory properties that may help reduce symptoms of inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease (IBD), and psoriasis. Fish oil supplements or regular consumption of fatty fish may help alleviate joint pain, stiffness, and inflammation in individuals with arthritis.
Pregnancy and Fetal Development: Consuming fish during pregnancy provides essential nutrients such as protein, omega-3 fatty acids, and vitamins and minerals like iodine and selenium that support fetal growth and development. However, pregnant women should choose low-mercury fish varieties and limit consumption of high-mercury fish to reduce the risk of mercury exposure to the developing fetus.
Bone Health: Certain types of fish, such as canned salmon with bones or sardines, are rich sources of calcium and vitamin D, which are essential for bone health and may help prevent osteoporosis and fractures, especially in older adults.
Depression and Mood Disorders: Some studies suggest that omega-3 fatty acids may have antidepressant effects and may help reduce symptoms of depression and anxiety. Regular consumption of fish or omega-3 supplements may support mental well-being and improve mood.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
Taxonomy | Rank | Effect | Citations | Notation |
---|---|---|---|---|
Terrabacteria group | clade | Increases | 👪 Source Study | |
Bacilli | class | Increases | 👶 Source Study | |
Clostridia | class | Increases | 👶 Source Study | |
Desulfuribacillia | class | Increases | 👶 Source Study | |
Dethiobacteria | class | Increases | 👶 Source Study | |
Erysipelotrichia | class | Increases | 👶 Source Study | |
Limnochordia | class | Increases | 👶 Source Study | |
Negativicutes | class | Increases | 👶 Source Study | |
Thermolithobacteria | class | Increases | 👶 Source Study | |
Tissierellia | class | Increases | 👶 Source Study | |
Desulforamulus | genus | Increases | 👪 Source Study | |
Bacillota sensu stricto incertae sedis | no rank | Increases | 👶 Source Study | |
environmental samples | no rank | Increases | 👶 Source Study | |
unclassified Bacillota | no rank | Increases | 👶 Source Study | |
Bacillota | phylum | Increases | 📓 Source Study | |
Desulforamulus hydrothermalis | species | Increases | 📓 Source Study |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.8 | 0.6 | 0.33 |
ADHD | 0.8 | 0.8 | |
Allergies | 0.2 | 0.2 | 0 |
Alopecia (Hair Loss) | 0.6 | -0.6 | |
Alzheimer's disease | 0.8 | 0.8 | |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | 0.6 | |
Ankylosing spondylitis | 0.2 | -0.2 | |
Anorexia Nervosa | 0.2 | 0.2 | 0 |
Asthma | 0.6 | 0.6 | |
Autism | 0.6 | 0.6 | |
Bipolar Disorder | 0.6 | 0.6 | 0 |
Celiac Disease | 0.6 | 0.6 | |
Chronic Fatigue Syndrome | 0.6 | 0.6 | |
Chronic Kidney Disease | 0.6 | 0.6 | |
Coagulation / Micro clot triggering bacteria | 0.2 | -0.2 | |
Colorectal Cancer | 0.2 | -0.2 | |
COVID-19 | 0.6 | 0.8 | -0.33 |
Crohn's Disease | 1 | 0.2 | 4 |
Depression | 0.8 | 0.6 | 0.33 |
Dermatomyositis | 0.6 | 0.6 | |
Endometriosis | 0.6 | -0.6 | |
Eosinophilic Esophagitis | 0.8 | 0.8 | |
Epilepsy | 0.6 | 0.6 | 0 |
Functional constipation / chronic idiopathic constipation | 0.6 | 0.6 | 0 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | -0.6 | |
Gout | 0.4 | -0.4 | |
Graves' disease | 0.8 | 0.2 | 3 |
Heart Failure | 0.2 | -0.2 | |
Hidradenitis Suppurativa | 0.6 | 0.6 | |
Hyperlipidemia (High Blood Fats) | 0.2 | 0.2 | |
Inflammatory Bowel Disease | 0.6 | 0.6 | 0 |
Insomnia | 0.6 | 0.6 | |
Irritable Bowel Syndrome | 0.6 | 0.2 | 2 |
Juvenile idiopathic arthritis | 0.6 | 0.6 | |
Long COVID | 1 | 0.2 | 4 |
Lung Cancer | 0.2 | 0.2 | |
Metabolic Syndrome | 0.8 | 0.6 | 0.33 |
Mood Disorders | 0.8 | 0.8 | 0 |
Multiple Sclerosis | 0.6 | 0.2 | 2 |
Neuropathy (all types) | 0.6 | -0.6 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.6 | 0.6 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.2 | -0.2 | |
Obesity | 0.8 | 0.6 | 0.33 |
Osteoarthritis | 0.6 | 0.6 | |
Osteoporosis | 0.6 | 0.6 | |
Parkinson's Disease | 0.8 | 0.8 | |
Psoriasis | 1 | -1 | |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.6 | 0.6 | |
Rosacea | 0.6 | 0.6 | |
Schizophrenia | 0.6 | 0.2 | 2 |
Sjögren syndrome | 0.6 | -0.6 | |
Sleep Apnea | 0.6 | -0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | 0.6 | |
Stress / posttraumatic stress disorder | 0.6 | 0.6 | |
Systemic Lupus Erythematosus | 0.8 | 0.2 | 3 |
Type 1 Diabetes | 0.6 | -0.6 | |
Type 2 Diabetes | 0.8 | 0.6 | 0.33 |
Ulcerative colitis | 1 | 0.8 | 0.25 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.